Acurx Pharmaceuticals (ACXP) Short Interest Ratio & Short Volume → Secret energy grid to power millions of homes (From Porter & Company) (Ad) Free ACXP Stock Alerts $2.40 +0.03 (+1.27%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Acurx Pharmaceuticals Short Interest DataCurrent Short Interest595,600 sharesPrevious Short Interest615,500 sharesChange Vs. Previous Month-3.23%Dollar Volume Sold Short$1.34 millionShort Interest Ratio7.4 Days to CoverLast Record DateMay 15, 2024Outstanding Shares15,840,000 sharesFloat Size13,430,000 sharesShort Percent of Float4.43%Today's Trading Volume19,365 sharesAverage Trading Volume129,675 sharesToday's Volume Vs. Average15% Short Selling Acurx Pharmaceuticals ? Sign up to receive the latest short interest report for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACXP Short Interest Over TimeACXP Days to Cover Over TimeACXP Percentage of Float Shorted Over Time Ad Paradigm PressAfter Conviction, More Bad News for TrumpAs a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown.Click here to see the details because this coming election meltdown could trigger… Acurx Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024595,600 shares $1.34 million -3.2%4.4%7.4 $2.25 4/30/2024615,500 shares $1.38 million +6.3%4.7%7.4 $2.25 4/15/2024579,100 shares $946,828.50 +71.6%4.8%5.6 $1.64 3/31/2024337,400 shares $826,630.00 +14.6%2.8%2 $2.45 3/15/2024294,500 shares $801,040.00 +0.9%2.5%1.7 $2.72 2/29/2024291,900 shares $837,753.00 -3.2%2.6%1.3 $2.87 Get the Latest News and Ratings for ACXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024301,500 shares $919,575.00 -12.3%2.7%1.3 $3.05 1/31/2024343,700 shares $1.12 million +41.1%3.0%1.4 $3.27 1/15/2024243,600 shares $1.13 million -18.5%2.1%0.7 $4.63 12/31/2023298,800 shares $1.14 million -32.0%2.6%0.5 $3.83 12/15/2023439,100 shares $1.54 million -21.0%3.9%0.5 $3.50 11/30/2023555,800 shares $1.96 million -14.3%5.0%0.7 $3.52 11/15/2023648,300 shares $2.23 million -31.5%5.8%0.9 $3.44 10/31/2023946,100 shares $5.06 million -9.0%9.0%1.3 $5.35 10/15/20231,040,000 shares $4.51 million +10,197.0%9.9%1.6 $4.34 9/30/202310,100 shares $15,150.00 +50.8%0.1%0 $1.50 9/15/20236,700 shares $11,859.00 -51.1%0.1%0.2 $1.77 8/31/202313,700 shares $26,441.00 +95.7%0.1%0.4 $1.93 8/15/20237,000 shares $11,200.00 -63.0%0.1%0.2 $1.60 7/31/202318,900 shares $38,367.00 +42.1%0.2%0.7 $2.03 7/15/202313,300 shares $28,462.00 +58.3%0.1%0.5 $2.14 6/30/20238,400 shares $22,260.00 -27.6%0.1%0.3 $2.65 6/15/202311,600 shares $31,900.00 +39.8%0.1%0.5 $2.75 5/31/20238,300 shares $25,730.00 -60.9%0.1%0.3 $3.10 5/15/202321,200 shares $71,868.00 -7.0%0.2%0.7 $3.39 4/30/202322,800 shares $68,172.00 +4.1%0.3%0.7 $2.99 4/15/202321,900 shares $64,824.00 -25.5%0.2%0.7 $2.96 3/31/202329,400 shares $101,724.00 -52.8%0.3%0.9 $3.46 3/15/202362,300 shares $212,443.00 +150.2%0.7%1.8 $3.41 2/28/202324,900 shares $82,419.00 -33.8%0.3%0.7 $3.31 2/15/202337,600 shares $131,976.00 +78.2%0.4%1.2 $3.51 1/31/202321,100 shares $75,960.00 -7.9%0.2%0.7 $3.60 1/15/202322,900 shares $97,325.00 -3.4%0.2%0.9 $4.25 12/30/202223,700 shares $94,326.00 -18.0%0.3%1 $3.98 12/15/202228,900 shares $112,710.00 +26.8%0.3%1.4 $3.90 11/30/202222,800 shares $72,732.00 -1.3%0.2%1 $3.19 11/15/202223,100 shares $72,072.00 +5.5%0.3%1 $3.12 10/31/202221,900 shares $67,452.00 -27.2%0.2%0.8 $3.08 10/15/202230,100 shares $88,795.00 -22.2%0.3%1.1 $2.95 9/30/202238,700 shares $116,100.00 +45.5%0.4%1.5 $3.00Secret energy grid to power millions of homes (Ad)This high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type of energy system the world has never seen before.Click here to get all the details. 9/15/202226,600 shares $103,740.00 +10.8%0.3%1 $3.90 8/31/202224,000 shares $83,760.00 -34.1%0.3%0.9 $3.49 8/15/202236,400 shares $164,164.00 -13.5%0.4%1.6 $4.51 7/31/202242,100 shares $150,718.00 +89.6%0.5%2.1 $3.58 7/15/202222,200 shares $80,475.00 -43.9%N/A1.4 $3.63 6/30/202239,600 shares $150,084.00 -29.9%N/A2.5 $3.79 6/15/202256,500 shares $213,570.00 +16.3%N/A3.2 $3.78 5/31/202248,600 shares $130,734.00 -1.2%N/A2.8 $2.69 5/15/202249,200 shares $133,332.00 +39.4%N/A2.7 $2.71 4/30/202235,300 shares $131,669.00 -59.2%N/A2 $3.73 4/15/202286,600 shares $346,400.00 -22.3%N/A3.3 $4.00 3/31/2022111,400 shares $365,392.00 +136.5%N/A4 $3.28 3/15/202247,100 shares $175,683.00 +9.0%N/A1.6 $3.73 2/28/202243,200 shares $157,209.12 -53.7%N/A1.4 $3.64 2/15/202293,300 shares $375,999.00 -4.3%N/A2.6 $4.03 1/31/202297,500 shares $405,600.00 -28.8%N/A2.3 $4.16 1/15/2022137,000 shares $627,460.00 -16.2%N/A3 $4.58 12/31/2021163,400 shares $706,116.76 -6.0%N/A3.6 $4.32 12/15/2021173,800 shares $716,056.00 +52.2%N/A2.9 $4.12 11/30/2021114,200 shares $548,160.00 -17.1%N/A1.9 $4.80 11/15/2021137,700 shares $684,369.00 +14.9%N/A2.2 $4.97 10/29/2021119,800 shares $599,000.00 +17.7%N/A1.7 $5.00 10/15/2021101,800 shares $499,838.00 -4.9%N/A1.2 $4.91 9/30/2021107,000 shares $549,980.00 +11.2%N/A0.8 $5.14 9/15/202196,200 shares $485,810.00 +24.9%N/A0.2 $5.05 8/31/202177,000 shares $398,090.00 -35.9%N/A0.1 $5.17 8/13/2021120,100 shares $576,480.00 No ChangeN/A0.1 $4.80 ACXP Short Interest - Frequently Asked Questions What is Acurx Pharmaceuticals' current short interest? Short interest is the volume of Acurx Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 595,600 shares of ACXP short. 4.43% of Acurx Pharmaceuticals' shares are currently sold short. Learn More on Acurx Pharmaceuticals' current short interest. What is a good short interest ratio for Acurx Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACXP shares currently have a short interest ratio of 7.0. Learn More on Acurx Pharmaceuticals's short interest ratio. Which institutional investors are shorting Acurx Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Acurx Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Acurx Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.43% of Acurx Pharmaceuticals' floating shares are currently sold short. Is Acurx Pharmaceuticals' short interest increasing or decreasing? Acurx Pharmaceuticals saw a drop in short interest in May. As of May 15th, there was short interest totaling 595,600 shares, a drop of 3.2% from the previous total of 615,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acurx Pharmaceuticals' float size? Acurx Pharmaceuticals currently has issued a total of 15,840,000 shares. Some of Acurx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acurx Pharmaceuticals currently has a public float of 13,430,000 shares. How does Acurx Pharmaceuticals' short interest compare to its competitors? 4.43% of Acurx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acurx Pharmaceuticals: Indaptus Therapeutics, Inc. (0.28%), Aytu BioPharma, Inc. (7.82%), Werewolf Therapeutics, Inc. (1.25%), Sagimet Biosciences Inc. (10.29%), I-Mab (1.46%), Repare Therapeutics Inc. (1.82%), Veru Inc. (8.65%), scPharmaceuticals Inc. (21.81%), Regulus Therapeutics Inc. (5.44%), Syros Pharmaceuticals, Inc. (7.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Acurx Pharmaceuticals stock? Short selling ACXP is an investing strategy that aims to generate trading profit from Acurx Pharmaceuticals as its price is falling. ACXP shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acurx Pharmaceuticals? A short squeeze for Acurx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACXP, which in turn drives the price of the stock up even further. How often is Acurx Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACXP, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Indaptus Therapeutics Short Interest Aytu BioPharma Short Interest Werewolf Therapeutics Short Interest Sagimet Biosciences Short Interest I-Mab Short Interest Repare Therapeutics Short Interest Veru Short Interest scPharmaceuticals Short Interest Regulus Therapeutics Short Interest Syros Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACXP) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.